Miragen Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Miragen Therapeutics by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $330k | 15k | 21.78 |
2023-09-30 | $233k | 15k | 15.34 |
2023-06-30 | $601k | 24k | 25.44 |
2023-03-31 | $601k | 24k | 25.44 |
2022-12-31 | $569k | 20k | 29.21 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas